This inventor holds 4 USPTO granted patents. Top assignees: Gruenenthal Gmbh, Basf Aktiengesellschaft. Active years: 1997-2004.
Location History:
- Aachen, DE (1997 - 1998)
- Loerrach, DE (2001)
- Bonn, DE (2004)
Company Filing History:
Years Active: 1997-2004
Title: Juergen Betzing: Innovator in Pharmaceutical Patents
Introduction
Juergen Betzing is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. With a total of 4 patents to his name, Betzing's work focuses on enhancing the efficacy and safety of medicinal preparations.
Latest Patents
Among his latest patents, Betzing has developed an opioid analgesic with controlled active substance release. This orally administered preparation features a controlled release of an opioid analgesic in the form of crystals, with a particle size ranging from 10 µm to 3 mm, preferably between 50 µm and 1 mm, and includes at least one controlled release coating. Another significant patent involves oral medicinal preparations that ensure reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates. This innovation consists of solid medicinal forms with a multiphase structure for oral administration, incorporating various auxiliary substances to optimize the delivery of gatifloxacin.
Career Highlights
Throughout his career, Juergen Betzing has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Grünenthal GmbH and BASF Aktiengesellschaft. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.
Collaborations
Betzing has collaborated with esteemed colleagues, including Johannes Heinrich Bartholomaeus and Kurt H. Bauer. These partnerships have contributed to the advancement of his research and the successful development of his patented innovations.
Conclusion
Juergen Betzing's contributions to pharmaceutical innovations highlight his commitment to improving drug delivery systems. His patents reflect a deep understanding of medicinal chemistry and a dedication to enhancing patient care through effective pharmaceutical solutions.